At the University of Wisconsin System Board of Regents meeting last week, the Capital Planning and Budget Committee recommended and the full Board approved a request for UW–Madison to enter into a lease for nearly 51,000 square feet at the anticipated Element Labs location at...
Exact Sciences Corp. today announced data from a multi-cancer early detection (MCED) biomarker validation study was presented at the ESMO Congress. The study rigorously assessed the performance of four distinct biomarker classes found in the blood and known to signal the presence of cancer regardless...
This study is the first of its kind to evaluate M2SR in children under 9 years old, a population with the greatest rates of flu infection each year and who are at higher risk of serious complications or death....
Thirty companies have been selected as finalists for the 2022 Wisconsin Innovation Awards. In total, more than 300 businesses, products, and services from around the state were nominated....
President Joe Biden signed a bill last week which will allocate more than $280 billion over five years into the U.S. semiconductor chip industry....
Regional technology “hub” proposals are already being written in Wisconsin, with topic areas that touch on food, water, energy resiliency, manufacturing and generally making better use of resources....
"This ADAPT Triad project with WSG offers a tremendous opportunity to help inform treatment decisions and recurrence monitoring, and ultimately improve future outcomes for breast cancer patients," said Rick Baehner, MD, chief medical officer of Precision Oncology for Exact Sciences. "...
For the 11th consecutive year, U.S. News & World Report ranked University of Wisconsin Hospitals, which includes University Hospital and UW Health East Madison Hospital, as No. 1 in Wisconsin on its Best Hospitals list....
FluGen announced the dosing of its first subject in an unprecedented study of older adults ages 65-85 years. The study will evaluate the safety, tolerability, and immunological response to FluGen's investigational supra-seasonal, live, single-replication, intranasal M2SR influenza (flu) vaccine....
Ultima Genomics, Inc. and Exact Sciences Corporation (Nasdaq: EXAS) have entered a long-term supply agreement for Ultima's next-generation sequencing (NGS) technologies. ...